Chicago—With more than 1,000 active clinical trial protocols at the University of Texas MD Anderson Cancer Center, in Houston, it’s critical for Sapna R. Amin, PharmD, the center’s manager of investigational pharmacy services, and her colleagues to use a set approach so a flood of data and complex logistics does not overwhelm them.
“We are trying to standardize the nonstandard,” Dr. Amin said during a session at the 2016 annual